Mild side effects of Zepbound that have been reported include ... Zepbound has a boxed warning about a possible risk of thyroid cancer. A boxed warning is the most serious warning from the ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Zepbound's side effects can include nausea, diarrhea, vomiting, constipation, stomach discomfort and pain. Other side effects include fatigue, allergic reactions, burping, hair loss and ...

Like many medications, both Zepbound and Wegovy come with potential side effects, primarily gastrointestinal issues. “[Both] can both cause nausea, upset stomach, vomiting and bowel issues ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.